Miromatrix Medical Inc Revenue Growth Rates (MIRO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Miromatrix Medical inc   (NASDAQ: MIRO)
 

MIRO's Revenue Growth by Quarter and Year

Miromatrix Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MIRO Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September 0.01
2nd Quarter June 0.01
1st Quarter March 0.01
FY 0.03





MIRO Revenue third quarter 2023 Y/Y Growth Comment
Miromatrix Medical inc achieved in the third quarter 2023, above Company average Revenue increase of 11.76% year on year, to $ 0.01 millions.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 43 other companies have achieved higher Revenue growth. While Miromatrix Medical Inc ' s Revenue growth of 11.76% ranks overall at the positon no. 2871 in the third quarter 2023.


MIRO Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - 9200 % -66.67 % -
3rd Quarter September 11.76 % 0 % 0 % -
2nd Quarter June - - 0 % -
1st Quarter March 0 % 0 % - -
FY   - 2275 % -20 % -

Financial Statements
Miromatrix Medical Inc 's third quarter 2023 Revenue $ 0.01 millions MIRO's Income Statement
Miromatrix Medical Inc 's third quarter 2022 Revenue $ 0.01 millions Quarterly MIRO's Income Statement


MIRO Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 9200 % 0 % 200 %
3rd Quarter September 11.76 % - 0 % 0 %
2nd Quarter June 0 % - 0 % -
1st Quarter March -98.92 % 0 % -66.67 % -
FY (Year on Year)   - 2275 % -20 % -


Back to MIRO Growth rate Comparisons >> Back to MIRO Growth rate Comparisons >>


Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #464
Overall #2871

Revenue Y/Y Growth Statistics
High Average Low
-9.83 % -9.83 % -9.83 %
(Sep 30 2023)  
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #464
Overall #2871
Revenue Y/Y Growth Statistics
High Average Low
-9.83 % -9.83 % -9.83 %
(Sep 30 2023)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Miromatrix Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
9268.82 % 2301.86 % -99.31 %
(Dec 31 2022)  


MIRO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Miromatrix Medical Inc disclosed increase in Revenue from the second quarter by 11.76% to $ 0.01 millions, from $ 0.01 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Miromatrix Medical Inc 's Revenue growth quarter on quarter, overall rank is 340.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #30
Healthcare Sector #123
Overall #340
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #30
Healthcare Sector #123
Overall #340
Revenue Q/Q Growth Statistics
High Average Low
9268.82 % 2301.86 % -99.31 %
(Dec 31 2022)  


MIRO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Miromatrix Medical Inc disclosed increase in Revenue from the second quarter by 11.76% to $ 0.01 millions, from $ 0.01 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Miromatrix Medical Inc 's Revenue growth quarter on quarter, overall rank is 340.


Miromatrix Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 0.96 $ 0.96 $ 0.95 $ 0.95 $ 0.03
Y / Y Revenue Growth (TTM) 2971.1 % 3254.01 % 2729.75 % 2786.13 % -39.24 %
Year on Year Revenue Growth Overall Ranking # 13 # 12 # 25 # 22 # 4090
Seqeuential Revenue Change (TTM) -0.13 % 0.47 % 0.12 % 2956.74 % 9.07 %
Seq. Revenue Growth (TTM) Overall Ranking # 2246 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
Assuming the Miromatrix Medical Inc 's fiscal year would have ended in Sep 30 2023, Miromatrix Medical Inc would have reprted above average annual Revenue surge of 2971.1% year on year, of $ 1 millions.
This marks a slow-down of the companys growth trends and from the 3254.01% surge in Jun 30 2023.

In the Healthcare sector 553 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 12 to 13.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 60
Healthcare Sector # 554
Overall # 3873

Revenue TTM Y/Y Growth Statistics
High Average Low
3254.01 %
 1660.08 %
-45.36 %
(Jun 30 2023)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 367
S&P 500 # 2246
Cumulative Revenue growth Comment
Assuming the Miromatrix Medical Inc 's fiscal year would have ended in Sep 30 2023, Miromatrix Medical Inc would have reprted above average annual Revenue surge of 2971.1% year on year, of $ 1 millions.
This marks a slow-down of the companys growth trends and from the 3254.01% surge in Jun 30 2023.

In the Healthcare sector 553 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 12 to 13.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 60
Healthcare Sector # 554
Overall # 3873

Revenue TTM Y/Y Growth Statistics
High Average Low
3254.01 %
1660.08 %
-45.36 %
(Jun 30 2023)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 367
S&P 500 # 2246




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MIRO's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Becton Dickinson And Company20.46%$ 20.459 millions
Apyx Medical Corp20.45%$ 20.452 millions
Deciphera Pharmaceuticals Inc 20.40%$ 20.401 millions
Airsculpt Technologies Inc 20.32%$ 20.315 millions
Zai Lab Limited20.31%$ 20.313 millions
Zynex inc 20.22%$ 20.219 millions
Alpine Immune Sciences Inc 20.03%$ 20.031 millions
Lemaitre Vascular Inc 19.95%$ 19.952 millions
Irhythm Holdings Inc 19.83%$ 19.831 millions
Bolt Biotherapeutics Inc 19.70%$ 19.697 millions
Mimedx Group Inc 19.55%$ 19.550 millions
Veracyte Inc 19.20%$ 19.203 millions
Sanuwave Health Inc 18.89%$ 18.891 millions
Silk Road Medical Inc 18.76%$ 18.759 millions
Werewolf Therapeutics Inc 18.65%$ 18.652 millions
Quanterix Corporation18.65%$ 18.652 millions
Cano Health Inc 18.50%$ 18.502 millions
The Pennant Group Inc 18.46%$ 18.455 millions
Vericel Corporation18.24%$ 18.236 millions
United Therapeutics Corporation18.10%$ 18.101 millions
Integer Holdings Corporation18.06%$ 18.056 millions
Guardion Health Sciences Inc 17.82%$ 17.818 millions
Kamada Ltd 17.75%$ 17.745 millions
Heron Therapeutics Inc 17.58%$ 17.581 millions
Atricure Inc 17.57%$ 17.566 millions
10x Genomics Inc 17.47%$ 17.471 millions
Sanara Medtech Inc 17.09%$ 17.088 millions
Infusystem Holdings Inc16.97%$ 16.973 millions
Msa Safety Inc16.88%$ 16.876 millions
Twist Bioscience Corporation16.82%$ 16.820 millions


About Miromatrix Medical Inc Revenue Growth Rates (MIRO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Miromatrix Medical Inc (CIK 1527096).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-23-019009
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Miromatrix Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.